Post Tagged with: "hepatocellular carcinoma (HCC)"

Editor’s Pick: Hepatocellular Carcinoma. Part 1: Epidemiology, Risk Factors, Pathogenesis, and Pathology

Editor’s Pick: Hepatocellular Carcinoma. Part 1: Epidemiology, Risk Factors, Pathogenesis, and Pathology

Hepatology June 8, 2017 at 8:26 AM 0 comments

Our Editor’s Pick for this edition of EMJ Hepatology is a tripartite paper by Charach et al. encompassing hepatocellular carcinoma, which is a common cause of cancer-related death in both men and women. This thorough review provides excellent detail on the development, clinical presentation, diagnosis, and treatment of the disease.Read More

Hepatocellular Carcinoma. Part 2: Clinical Presentation and Diagnosis

Hepatocellular Carcinoma. Part 2: Clinical Presentation and Diagnosis

Hepatology June 8, 2017 at 8:25 AM 0 comments

Lior Charach, Lior Zusmanovitch, *Gideon Charach Department of Internal Medicine C, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel *Correspondence to drcharach@012.net.il Disclosure: The authors have declared no conflicts of interest. Received: 18.01.17 Accepted: 04.05.17 Citation: EMJ Hepatol. 2017;5[1]:81-88. Abstract Clinical presentation ofRead More

Hepatocellular Carcinoma. Part 3: Surgical and Medical Treatment

Hepatocellular Carcinoma. Part 3: Surgical and Medical Treatment

Hepatology June 8, 2017 at 8:24 AM 0 comments

Lior Charach, Lior Zusmanovitch, *Gideon Charach Department of Internal Medicine C Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel *Correspondence to drcharach@012.net.il Disclosure: The authors have declared no conflicts of interest. Received: 18.01.17 Accepted: 08.05.17 Citation: EMJ Hepatol. 2017;5[1]:89-96. Abstract Hepatocellular carcinoma (HCC)Read More

Recent Developments in Regorafenib Treatment for Gastrointestinal Cancers: Presentations at the 2016 Meeting of the European Society for Medical Oncology (ESMO) Congress 2016

Recent Developments in Regorafenib Treatment for Gastrointestinal Cancers: Presentations at the 2016 Meeting of the European Society for Medical Oncology (ESMO) Congress 2016

European Medical Journal, Oncology December 13, 2016 at 8:26 AM 0 comments

Axel Grothey,1 Gerald Prager,2 *Jean-Yves Blay3 1. Mayo Clinic, Mayo Clinic College of Medicine, Rochester, Minnesota, USA 2. Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria 3. Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France *Correspondence to jean-yves.blay@lyon.unicancer.fr Disclosure: Prof Jean-Yves Blay hasRead More

Editor’s Pick: Clinical, Histological, and Molecular Classification of Hepatocellular Carcinoma: How Do They Get Along?

Editor’s Pick: Clinical, Histological, and Molecular Classification of Hepatocellular Carcinoma: How Do They Get Along?

Hepatology May 31, 2016 at 8:28 AM 0 comments

In this next article, Luca Quagliata of the Institute of Pathology, University Hospital of Basel,  Basel, Switzerland, discusses the integration of the histological, clinical, and molecular classifications of hepatocellular carcinoma. This is a field of ongoing research without any final conclusions, and thus the data is difficult to interpret. ThisRead More

Alcoholic Liver Disease: A Comprehensive Review

Alcoholic Liver Disease: A Comprehensive Review

European Medical Journal, Hepatology April 5, 2016 at 8:48 AM 0 comments

Partha Pal,1 *Sayantan Ray2 1. Department of Medical Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India 2. Department of Endocrinology, Institute of Post Graduate Medical Education & Research (IPGMER) and SSKM Hospital, Kolkata, India *Correspondence to sayantan.ray30@gmail.com Disclosure: The authors have declared no conflicts of interest. Received: 17.11.15 Accepted: 02.02.16 Citation:Read More